Sunway Healthcare Holdings Berhad (KLSE:SUNMED)
Malaysia · Delayed Price · Currency is MYR 1.780
+0.030 (1.71%)
At close: Jun 10, 2026
KLSE:SUNMED Cash Flow Statement
Financials in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Net Income | 246.79 | 252.21 | 257.5 | 181.63 | 209.9 |
Depreciation & Amortization | 202.87 | 188.94 | 130.65 | 117.59 | 86.54 |
Other Amortization | 11.34 | 11.34 | 9.9 | 6.2 | 4.66 |
Loss (Gain) From Sale of Assets | -0.23 | -0.12 | 0.24 | 0.2 | 0.07 |
Asset Writedown & Restructuring Costs | 0.33 | 0.33 | 0.82 | 0.26 | 0.37 |
Provision & Write-off of Bad Debts | 7.83 | 7.6 | 8.09 | 3.41 | 3.42 |
Other Operating Activities | 19.7 | 0.15 | 21.96 | 40.8 | -19.96 |
Change in Accounts Receivable | -19.68 | -25.6 | -35.43 | -93.66 | -54.77 |
Change in Inventory | -25.27 | -18.45 | -12.94 | -18.28 | -19.28 |
Change in Accounts Payable | 63.64 | 67.49 | 25.18 | 64.48 | 28.33 |
Change in Other Net Operating Assets | -49.65 | -18.22 | 14.5 | -8.45 | -41.13 |
Operating Cash Flow | 458.51 | 465.66 | 420.47 | 294.16 | 198.15 |
Operating Cash Flow Growth | 55.87% | 10.75% | 42.94% | 48.45% | - |
Capital Expenditures | -430.38 | -576.01 | -531.12 | -883.95 | -619.73 |
Sale of Property, Plant & Equipment | 2.36 | 2.41 | 1.5 | 2.15 | 1.08 |
Sale (Purchase) of Intangibles | -4.59 | -3.04 | -6.92 | -7.4 | -6.65 |
Investment in Securities | - | - | 63.67 | -7.47 | 191.59 |
Other Investing Activities | 23.46 | 25.13 | 17.34 | 7.04 | 7.42 |
Investing Cash Flow | -409.15 | -551.52 | -455.53 | -889.63 | -426.3 |
Long-Term Debt Issued | - | 964.9 | 681.48 | 697.86 | - |
Long-Term Debt Repaid | - | -449.54 | -316.53 | -53.13 | -150.05 |
Net Debt Issued (Repaid) | 841.03 | 515.36 | 364.95 | 644.73 | -150.05 |
Issuance of Common Stock | 28.5 | 28.5 | 168 | - | 410 |
Common Dividends Paid | -727.74 | -622.5 | -11.52 | -9 | -4.51 |
Other Financing Activities | -64.6 | -59.22 | -46.22 | -19.91 | -15.14 |
Financing Cash Flow | 77.19 | -137.85 | 757.21 | 615.82 | 240.3 |
Foreign Exchange Rate Adjustments | -0.96 | -0.97 | 0.06 | - | - |
Net Cash Flow | 125.59 | -224.68 | 722.21 | 20.35 | 12.15 |
Free Cash Flow | 28.13 | -110.35 | -110.66 | -589.79 | -421.58 |
Free Cash Flow Margin | 1.22% | -5.01% | -5.97% | -40.48% | -39.59% |
Free Cash Flow Per Share | 0.00 | -0.01 | -0.01 | -0.05 | -0.04 |
Cash Interest Paid | 64.59 | 59.21 | 46.2 | 19.9 | 15.14 |
Cash Income Tax Paid | 37.8 | 48.15 | 49.88 | 33.27 | 6.17 |
Levered Free Cash Flow | - | -268.34 | 282.3 | -1,053 | - |
Unlevered Free Cash Flow | - | -231.34 | 311.18 | -1,040 | - |
Change in Working Capital | -30.95 | 5.22 | -8.69 | -55.91 | -86.86 |